{
  "id": "clinical#screening_cues_b0642075",
  "content": "• Diseases of the nervous system (e.g. cerebral ischaemic stroke, cerebral palsy, epilepsy or\nseizures, hypoxic-ischaemic encephalopathy)\nNeurocognitive disorders | Amnestic disorder Neurocognitive disorders | Amnestic disorder\n616 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\n• Endocrine diseases (e.g. hypothyroidism)\n• Intracranial injury\n• Metabolic disorders (e.g. hypo-osmolality or hyponatraemia)\n• Neoplasms of the brain or central nervous system\n• Nutritional disorders (e.g. vitamin B or B deficiency)\n1 12\n6D72.1 Amnestic disorder due to psychoactive substances, including medications\nEssential (required) features\n• All diagnostic requirements for amnestic disorder are met.\n• There is evidence from history, physical examination or laboratory findings that the\ndisturbance is caused by the direct physiological consequences of use of a substance or\nmedication that persists beyond the usual duration of substance intoxication or substance\nwithdrawal. This judgement depends on establishing the following.\n• The substance or medication and the amount and duration of its use is known to be\ncapable of producing the memory disturbance.\n• The course of the memory disturbance (e.g. onset, trajectory of symptoms, response to\ntreatment) is consistent with causation by the substance or medication.",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues • Diseases of the nervous system (e.g. cerebral ischaemic stroke, cerebral palsy, epilepsy or\nseizures, hypoxic-ischaemic encephalopathy)\nNeurocognitive disorders | Amnestic disorder Neurocognitive disorders | Amnestic disorder\n616 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\n• Endocrine diseases (e.g. hypothyroidism)\n• Intracranial injury\n• Metabolic disorders (e.g. hypo-osmolality or hyponatraemia)\n• Neoplasms of the brain or central nervous system\n• Nutritional disorders (e.g. vitamin B or B deficiency)\n1 12\n6D72.1 Amnestic disorder due to psychoactive substances, including medications\nEssential (required) features\n• All diagnostic requirements for amnestic disorder are met.\n• There is evidence from history, physical examination or laboratory findings that the\ndisturbance is caused by the direct physiological consequences of use of a substance or\nmedication that persists beyond the usual duration of substance intoxication or substance\nwithdrawal. This judgement depends on establishing the following.\n• The substance or medication and the amount and duration of its use is known to be\ncapable of producing the memory disturbance.\n• The course of the memory disturbance (e.g. onset, trajectory of symptoms, response to\ntreatment) is consistent with causation by the substance or medication. • diseases of the nervous system (e.g. cerebral ischaemic stroke, cerebral palsy, epilepsy or\nseizures, hypoxic-ischaemic encephalopathy)\nneurocognitive disorders | amnestic disorder neurocognitive disorders | amnestic d..."
}